Amedisys Revenue, Profits - AMED Annual Income Statement

Add to My Stocks
$118.55 $1.01 (0.84%) AMED stock closing price Sep 21, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Amedisys stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $1.53B for 2017 impacts the AMED stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2017 is $1.53B and has increased from $1.44B year on year as is evident when you compare the latest figures in the latest Amedisys profit and loss statement with those of the prior corresponding period. Also see Amedisys assets and Amedisys free cash flow for a complete valuation of AMED stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Amedisys Revenues or Net Sales
Cost Of Goods Sold (COGS)900.72M833.05M725.91M691.06M717.99M841.14M782.34M820.46M724.46M562.63M
Amedisys Gross Profit
Research & Development Expense----------
Selling General & Admin Expense537.3M527.38M543.75M458.03M639.95M556.93M540.31M585.76M529.93M447.27M
Income Before Depreciation Depletion Amortization95.64M77.01M10.87M55.46M-108.6M89.82M147.7M228.09M259.06M177.5M
Depreciation Depletion Amortization17.12M19.67M20.03M31.41M46.36M202.02M618.56M34.58M28.31M20.4M
Non Operating Income7.3M9.38M19.64M5.14M5.9M5.67M-1.27M3.31M-
Interest Expense5.03M5.16M10.78M8.21M4.41M12.16M8.82M9.2M11.67M16.62M
Amedisys Pretax Income
Provision for Income Taxes50.11M23.93M2M7.67M-58.77M-21.39M-103.42M72.3M86.17M54.71M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations30.68M37.63M-2.31M13.3M-94.7M-97.3M-375.37M113.27M136.22M86.68M
Extraordinary Items & Discontinued Operations----0.21M-3.07M-1.28M-6.96M---
Amedisys Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS34.3M33.74M33.02M32.82M31.25M29.9M28.69M28.48M27.76M26.43M
Average Shares used to compute Basic EPS33.7M33.2M33.02M32.3M31.25M29.9M28.69M28.03M27.23M26.43M
Income Before Nonrecurring Items75.93M52.18M48.88M23.87M8.57M32.76M66.24M122.31M135.84M89.13M
Income from Nonrecurring Items-45.63M-14.92M-51.9M-10.88M-101.67M-115.07M-441.74M-9.73M--2.45M
Amedisys Earnings Per Share Basic Net
Amedisys Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items2.211.551.480.730.
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Amedisys stock analysis are:

  • Topline: A growing topline, as seen from the Amedisys revenue chart, as is the case with Amedisys indicates a growing business. One needs to compare the YoY topline or sales growth of AMED stock with its peers like EVHC stock and CHE stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $30.3M for AMED stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the AMED income statement, one can check the Amedisys historical stock prices to check how the price has moved with time.

Amedisys Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield